Home > Research > Publications & Outputs > Non-invasive assessment of digital vascular rea...
View graph of relations

Non-invasive assessment of digital vascular reactivity in patients with primary Raynaud’s phenomenon and systemic sclerosis.

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Published

Standard

Non-invasive assessment of digital vascular reactivity in patients with primary Raynaud’s phenomenon and systemic sclerosis. / Anderson, M. E.; Campbell, F.; Hollis, S. et al.
In: Clinical and Experimental Rheumatology, Vol. 17, No. 1, 1999, p. 49-54.

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Harvard

Anderson, ME, Campbell, F, Hollis, S, Moore, T, Jayson, MIV & Herrick, AL 1999, 'Non-invasive assessment of digital vascular reactivity in patients with primary Raynaud’s phenomenon and systemic sclerosis.', Clinical and Experimental Rheumatology, vol. 17, no. 1, pp. 49-54. <http://www.clinexprheumatol.org/pdf/vol17/17_1/abstract_1ande.html>

APA

Anderson, M. E., Campbell, F., Hollis, S., Moore, T., Jayson, M. I. V., & Herrick, A. L. (1999). Non-invasive assessment of digital vascular reactivity in patients with primary Raynaud’s phenomenon and systemic sclerosis. Clinical and Experimental Rheumatology, 17(1), 49-54. http://www.clinexprheumatol.org/pdf/vol17/17_1/abstract_1ande.html

Vancouver

Anderson ME, Campbell F, Hollis S, Moore T, Jayson MIV, Herrick AL. Non-invasive assessment of digital vascular reactivity in patients with primary Raynaud’s phenomenon and systemic sclerosis. Clinical and Experimental Rheumatology. 1999;17(1):49-54.

Author

Anderson, M. E. ; Campbell, F. ; Hollis, S. et al. / Non-invasive assessment of digital vascular reactivity in patients with primary Raynaud’s phenomenon and systemic sclerosis. In: Clinical and Experimental Rheumatology. 1999 ; Vol. 17, No. 1. pp. 49-54.

Bibtex

@article{1c292b1c182145609fd03830bd9bebe2,
title = "Non-invasive assessment of digital vascular reactivity in patients with primary Raynaud{\textquoteright}s phenomenon and systemic sclerosis.",
abstract = "Objective To examine digital microvascular responses in patients with primary Raynaud's phenomenon (PRP) and systemic sclerosis (SSc), and compare these to the responses in healthy control subjects. Methods Digital microvascular responses to repeated episodes of iontophoresis of acetylcholine chloride (endothelial-dependent), sodium nitroprusside (endothelial-independant) and adrenaline were measured using dual-channel laser Doppler in 8 healthy control subjects, 8 patients with PRP and 8 patients with SSc. Results There were no significant differences in responses between groups. For each chemical the greatest response was generally seen in period 7 of the protocol (after the third episode of iontophoresis). For acetylcholine chloride in period 7, the age and baseline adjusted ratio of the maximum response of PRP to control was 0.93, 95% CI (0.26, 3.38) and for SSc to control it was 0.60, 95% CI (0.13, 2.81). For sodium nitroprusside in period 7, this age and baseline adjusted ratio of the maximum response of PRP to control was 1.31, 95% CI (0.74, 2.32) and for SSc to control it was 1.35, 95% CI (0.68, 2.67). For adrenaline in period 7, the age and baseline adjusted ratio of PRP to control was 1.51, 95% CI (0.79, 2.89) and for SSc to control it was 2.18, 95% CI (1.01, 4.69). Conclusion This study demonstrates the usefulness of iontophoresis of vasoactive chemicals, combined with laser Doppler blood flowmetry, in the non-invasive assessment of dermal microvascular responses. One possible explanation for the lack of difference in responses between groups is that vasoactive chemicals other than those discussed are important in the pathophysiology of primary and secondary Raynaud's phenomenon.",
keywords = "Iontophoresis, laser Doppler, vascular responses, primary Raynaud's phenomenon, systemic sclerosis, scleroderma.",
author = "Anderson, {M. E.} and F. Campbell and S. Hollis and T. Moore and Jayson, {M. I. V.} and Herrick, {A. L.}",
year = "1999",
language = "English",
volume = "17",
pages = "49--54",
journal = "Clinical and Experimental Rheumatology",
publisher = "Clinical and Experimental Rheumatology S.A.S.",
number = "1",

}

RIS

TY - JOUR

T1 - Non-invasive assessment of digital vascular reactivity in patients with primary Raynaud’s phenomenon and systemic sclerosis.

AU - Anderson, M. E.

AU - Campbell, F.

AU - Hollis, S.

AU - Moore, T.

AU - Jayson, M. I. V.

AU - Herrick, A. L.

PY - 1999

Y1 - 1999

N2 - Objective To examine digital microvascular responses in patients with primary Raynaud's phenomenon (PRP) and systemic sclerosis (SSc), and compare these to the responses in healthy control subjects. Methods Digital microvascular responses to repeated episodes of iontophoresis of acetylcholine chloride (endothelial-dependent), sodium nitroprusside (endothelial-independant) and adrenaline were measured using dual-channel laser Doppler in 8 healthy control subjects, 8 patients with PRP and 8 patients with SSc. Results There were no significant differences in responses between groups. For each chemical the greatest response was generally seen in period 7 of the protocol (after the third episode of iontophoresis). For acetylcholine chloride in period 7, the age and baseline adjusted ratio of the maximum response of PRP to control was 0.93, 95% CI (0.26, 3.38) and for SSc to control it was 0.60, 95% CI (0.13, 2.81). For sodium nitroprusside in period 7, this age and baseline adjusted ratio of the maximum response of PRP to control was 1.31, 95% CI (0.74, 2.32) and for SSc to control it was 1.35, 95% CI (0.68, 2.67). For adrenaline in period 7, the age and baseline adjusted ratio of PRP to control was 1.51, 95% CI (0.79, 2.89) and for SSc to control it was 2.18, 95% CI (1.01, 4.69). Conclusion This study demonstrates the usefulness of iontophoresis of vasoactive chemicals, combined with laser Doppler blood flowmetry, in the non-invasive assessment of dermal microvascular responses. One possible explanation for the lack of difference in responses between groups is that vasoactive chemicals other than those discussed are important in the pathophysiology of primary and secondary Raynaud's phenomenon.

AB - Objective To examine digital microvascular responses in patients with primary Raynaud's phenomenon (PRP) and systemic sclerosis (SSc), and compare these to the responses in healthy control subjects. Methods Digital microvascular responses to repeated episodes of iontophoresis of acetylcholine chloride (endothelial-dependent), sodium nitroprusside (endothelial-independant) and adrenaline were measured using dual-channel laser Doppler in 8 healthy control subjects, 8 patients with PRP and 8 patients with SSc. Results There were no significant differences in responses between groups. For each chemical the greatest response was generally seen in period 7 of the protocol (after the third episode of iontophoresis). For acetylcholine chloride in period 7, the age and baseline adjusted ratio of the maximum response of PRP to control was 0.93, 95% CI (0.26, 3.38) and for SSc to control it was 0.60, 95% CI (0.13, 2.81). For sodium nitroprusside in period 7, this age and baseline adjusted ratio of the maximum response of PRP to control was 1.31, 95% CI (0.74, 2.32) and for SSc to control it was 1.35, 95% CI (0.68, 2.67). For adrenaline in period 7, the age and baseline adjusted ratio of PRP to control was 1.51, 95% CI (0.79, 2.89) and for SSc to control it was 2.18, 95% CI (1.01, 4.69). Conclusion This study demonstrates the usefulness of iontophoresis of vasoactive chemicals, combined with laser Doppler blood flowmetry, in the non-invasive assessment of dermal microvascular responses. One possible explanation for the lack of difference in responses between groups is that vasoactive chemicals other than those discussed are important in the pathophysiology of primary and secondary Raynaud's phenomenon.

KW - Iontophoresis

KW - laser Doppler

KW - vascular responses

KW - primary Raynaud's phenomenon

KW - systemic sclerosis

KW - scleroderma.

M3 - Journal article

VL - 17

SP - 49

EP - 54

JO - Clinical and Experimental Rheumatology

JF - Clinical and Experimental Rheumatology

IS - 1

ER -